Senior Director Laboratory Sciences
About the role
We are seeking a Senior Director, Laboratory Sciences for our Safety Assessment site located in Reno, NV. Direct the science and business involved in the conduct, direction, and execution of Laboratory Sciences operations and studies. Provide scientific direction, oversight, and guidance to staff. Maintain and implement efficient processes and procedures to provide high-quality standards of study design and timely reporting. Continue to build preclinical and clinical bioanalysis and biomarkers capabilities in an effort to expand the client base. Serve as the primary expert for Laboratory Sciences within the scientific community, presenting and speaking at meetings and interacting with new and prospective clients. Keep abreast and maintain a broad knowledge of state-of-the-art principles and theories.
Responsibilities
- Direct and oversee department activities to ensure achievement of department objectives.
- Lead interactions for Nevada Laboratory Sciences with sponsors, consultants, and other outside contacts; interact with government representatives and sponsors during site visits.
- Lead and promote new business development for Laboratory Sciences in Nevada as the primary scientific expert for existing and new clients.
- Continue to build preclinical and clinical bioanalysis and biomarkers capabilities to expand the client base.
- Evaluate opportunities for new technology and implement new scientific initiatives to add or expand services in Laboratory Sciences.
- Ensure coordination of study bids, study design and conduct, protocol review, consultant interactions, staffing needs, analysis, and reporting of Laboratory Sciences studies.
- Represent the organization to industry groups, key customers, representatives of government and regulatory agencies, and the general public.
- Ensure a positive employee relations position is maintained and that effective communication informs employees of plans and progress.
- Anticipate problems and initiate improvements.
- Maintain up-to-date knowledge of current industry practices.
- Monitor performance of direct reports. Provide regular coaching and counseling. Prepare and deliver salary and performance reviews. Review and approve performance and salary appraisals initiated by direct reports.
- Develop short- and long-range operating objectives, organizational structure, and staffing requirements. Oversee the development of a departmental plan for backup and succession of key departmental personnel.
- Ensure optimum performance of group function. Recommend and implement techniques to improve productivity, increase efficiencies, cut costs, take advantage of opportunities, and maintain state-of-the-art practices.
- Develop business leads to ensure the company’s financial success.
Requirements
- Master’s Degree in immunology, biochemistry, or a related scientific discipline required. PhD preferred.
- 10 years of relevant laboratory experience in a contract research organization (CRO), biotechnology, or pharmaceutical environment, working to Good Laboratory Practice (GLP) standards.
- 5 years of management experience, including staff management and development, and financial responsibility including budgets.
Skills
- Management and problem-solving skills.
- Demonstrated abilities in analytical, quantitative, and critical thinking.
- Ability to handle multiple projects, meet deadlines, and make executive-level decisions.
- Detail-oriented, flexible, with the ability to work well in a team-oriented environment.
- Proven ability to work in a dynamic, deadline-driven environment.
- Proficient project management, presentation, and communication skills.
- Proficient with computers and standard application software.
Pay
The hiring range for this position in the US is $210,000/yr - $235,000/yr. Please note that salaries vary within the range based on factors including, but not limited to, experience, skills, education, certifications, location, and any collective agreements, if applicable.
About Safety Assessment
Charles River is committed to helping our partners expedite their preclinical drug development with exceptional safety assessment services, state-of-the-art facilities, and expert regulatory guidance. From individual specialty toxicology and IND-enabling studies to tailored packages and total laboratory support, our deeply experienced team can design and execute programs that anticipate challenges and avoid roadblocks for a smooth, efficient journey to market. Each year approximately 300 investigational new drug (IND) programs are conducted in our Safety Assessment facilities.
About Charles River
Charles River is an early-stage contract research organization (CRO). We have built upon our foundation of laboratory animal medicine and science to develop a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP, to support clients from target identification through preclinical development. Charles River also provides a suite of products and services to support our clients’ clinical laboratory testing needs and manufacturing activities. Utilizing this broad portfolio of products and services enables our clients to create a more flexible drug development model, which reduces their costs, enhances their productivity and effectiveness to increase speed to market.
With over 20,000 employees within 110 facilities in over 20 countries around the globe, we are strategically positioned to coordinate worldwide resources and apply multidisciplinary perspectives in resolving our client’s unique challenges. Our client base includes global pharmaceutical companies, biotechnology companies, government agencies, hospitals, and academic institutions around the world. At Charles River, we are passionate about our role in improving the quality of people’s lives. Our mission, our excellent science, and our strong sense of purpose guide us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe. We have proudly worked on 80% of the drugs approved by the U.S. Food and Drug Administration (FDA) in the past five years.